Post-acute COVID-19

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-10-18
Clinical Trial Update: Safety and Dosage of a Computerized Cognitive Training Program for Cognitive Dysfunction After COVID-19 [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating safety and dosage of a computerized cognitive training program for cognitive dysfunction following …